MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.carrev.2018.07.012

Медицинская библиотека · Cardiovascular revascularization medicine : including molecular interventions · 2018

Exposure to glucocorticoids prior to transcatheter aortic valve replacement is associated with reduced incidence of high-degree AV block and pacemaker.

Oestreich Brett, Gurevich Sergey, Adabag Selcuk, Kelly Rosemary, Helmer Gregory, Raveendran Ganesh, Yannopoulos Demetris, Biring Timinder, Garcia Santiago

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Tissue edema and inflammation, which occur at the device landing zone during valve deployment, may contribute to the pathophysiology of conduction abnormalities after transcatheter aortic valve replacement (TAVR). We hypothesized that exposure to glucocorticoids prior to TAVR will reduce the incidence of conduction abnormalities requiring PPM implantation after TAVR.

METHODS

We included 167 consecutive patients treated with TAVR at the Minneapolis VA Medical Center and University of Minnesota. Exposure to glucocorticoids was assessed by linking electronic medical and pharmacy records. The primary outcome was a new PPM within 30 days of the index TAVR procedure.

RESULTS

Of the 167 patients included, 16 (9.5%) were exposed to glucocorticoids prior to TAVR. No differences in age, STS score, pre-existing right bundle branch block, implantation depth or valve type were seen among patients exposed to glucocorticoids versus those who were unexposed. Patients exposed to glucocorticoids were more likely to have moderate/severe COPD (43% versus 18%, p < 0.01). The cumulative incidence of PPM implantation at 30-days after TAVR was 18%. None of the patients exposed to glucocorticoids required a PPM while 30 (19%) of the unexposed patients did (p = 0.04).

CONCLUSIONS

Exposure to glucocorticoids prior to TAVR may be associated with reduced incidence of PPM requirement though larger studies are needed to support these findings. Tissue edema and inflammation may be significant contributors to the pathophysiology of conduction abnormalities after TAVR and could represent a therapeutic target.

Для цитирования: Oestreich Brett, Gurevich Sergey, Adabag Selcuk, Kelly Rosemary, Helmer Gregory, Raveendran Ganesh, Yannopoulos Demetris, Biring Timinder, Garcia Santiago. Exposure to glucocorticoids prior to transcatheter aortic valve replacement is associated with reduced incidence of high-degree AV block and pacemaker.. Cardiovascular revascularization medicine : including molecular interventions. 2018. DOI: 10.1016/j.carrev.2018.07.012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.